FDA issues CRL to ViroPharma for Cinryze manufacturing expansion activities
In the CRL, the FDA has asked for additional information related to observations from the pre-approval inspection and review of the technical processes. The company claims that Cinryze
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.